Repeated courses of escalating doses of Nivolumab in refractory Hodgkin lymphoma with recurrent relapses post allografting: A safe and effective treatment approach

por Kaloyannidis, Panayotis, Al Shaibani, Eshrak, Moinnudin, Asif, Al Anezi, Khalid, Al Hashmi, Hani
Publicado 2021

Combination of bortezomib plus ruxolitinib in steroid-refractory chronic graft-versus-host disease

por Kaloyannidis, Panayotis, Shaibani, Eshrak Al, Apostolidis, Ioannis, Kanfar, Solaf, Anezi, Khalid Al, Hashmi, Hani Al
Publicado 2018

De Novo Psoriasis Vulgaris Diagnosed after Nivolumab Treatment for Refractory Hodgkin's Lymphoma, Completely Resolved after Autologous Hematopoietic Stem Cell Transplantation

por Kaloyannidis, Panayotis, Al Shaibani, Eshrak, Mashhour, Miral, Gamil, Mohammed, Apostolidis, Ioannis, Al Hashmi, Hani, Al Anazi, Khalid Ahmed
Publicado 2018

Single-Agent High-Dose Melphalan as Conditioning Regimen in Autologous Hematopoietic Stem Cell Transplantation for Hodgkin's Lymphoma: Safety, and Long-Term Efficacy

por Al Hashmi, Hani, Kaloyannidis, Panayotis, Kafnar, Solaf, Al Harbi, Salman, Shaibani, Eshrak, Mokhtar, Nihad, Abdulbaki, Manar, Al Darweesh, Mohammed, Bacal, Jenifer, Apostolidis, John, Anezi, Khalid Al
Publicado 2018